Michele Garufi
Founder at NICOX SA
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-François Labbé | M | 73 |
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 14 years |
| Les Kaplan | M | 73 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 10 years |
| Lauren Silvernail | F | 65 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 7 years |
| Adrienne Graves | M | 69 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 10 years |
| Luzi Andreas von Bidder | M | 71 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 10 years |
| Gavin M. Spencer | M | 53 | 19 years | |
| Ilan Neugarten | M | 70 |
Nano Retina Ltd.
 Nano Retina Ltd. Medical SpecialtiesHealth Technology Nano Retina Ltd. develops artificial retina designed to restore sight. It also develops an implantable bionic chip, designed to return sight to those blinded by retinal degenerative diseases. The company was founded by Yossi Gross and James R. Von Her, II in 2009 and is headquartered in Herzliya, Israel. | - |
| Dan Rappaport | M | - |
Nano Retina Ltd.
Nano Retina Ltd. Medical SpecialtiesHealth Technology Nano Retina Ltd. develops artificial retina designed to restore sight. It also develops an implantable bionic chip, designed to return sight to those blinded by retinal degenerative diseases. The company was founded by Yossi Gross and James R. Von Her, II in 2009 and is headquartered in Herzliya, Israel. | - |
| Paolo Caputo | M | 74 |
University of Milan
| 39 years |
| Giuseppe Simoni | M | 80 |
University of Milan
| 36 years |
| Sandrine Gestin | F | 56 | 25 years | |
| Boaz Laor | M | 72 |
Nano Retina Ltd.
Nano Retina Ltd. Medical SpecialtiesHealth Technology Nano Retina Ltd. develops artificial retina designed to restore sight. It also develops an implantable bionic chip, designed to return sight to those blinded by retinal degenerative diseases. The company was founded by Yossi Gross and James R. Von Her, II in 2009 and is headquartered in Herzliya, Israel. | - |
| Emmanuelle Pierry | F | - | 22 years | |
| Doug Hubatsch | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Göran Albert Ando | M | 75 |
Novexel SA
 Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | 7 years |
| Maria Elisa D'Amico | F | - |
University of Milan
| 5 years |
| Luca Maria Rovere | M | - |
University of Milan
| 6 years |
| Philippe Masquida | M | 62 | 4 years | |
| Birgit Stattin Norinder | F | 75 | 7 years | |
| Sonia Maria Poli | M | 59 |
University of Milan
| 4 years |
| Vaughn M. Kailian | M | 79 | 13 years | |
| Piero del Soldato | M | - | 8 years | |
| Stefano Pareglio | M | 61 |
University of Milan
| 4 years |
| Massimo Sgrelli | M | - |
University of Milan
| 6 years |
| Stefano Bertola | M | 55 |
University of Milan
| 4 years |
| Silvio Broggi | M | 61 |
University of Milan
| 4 years |
| Elena Angela Carpani | F | 56 |
University of Milan
| 4 years |
| Francois Ducret | M | - | - | |
| Guido Répaci | M | - |
University of Milan
| 4 years |
| Silvia Restelli | F | - |
University of Milan
| 4 years |
| Filippo Zanetti | M | - |
University of Milan
| 5 years |
| Marco Mortali | M | 66 |
University of Milan
| 4 years |
| Roberto Franzo | M | 59 |
University of Milan
| 3 years |
| Sanjiv Sharma | M | 68 | 3 years | |
| Carlo Gandolfo Cerami | M | 59 |
University of Milan
| 4 years |
| Marco Guerra | M | - |
University of Milan
| 4 years |
| Nicola Cadei | M | - |
University of Milan
| 4 years |
| Stefano Giordani | M | - |
University of Milan
| 4 years |
| Umberto Zannier | M | - |
University of Milan
| 1 years |
| Vittoria Giustiniani | F | 60 |
University of Milan
| 3 years |
| Luigi Barni | M | 61 |
University of Milan
| 3 years |
| Daniele Conti | M | 60 |
University of Milan
| 4 years |
| Roberto Leonardi | M | - |
University of Milan
| 4 years |
| Piergiuseppe Caldana | M | 60 |
University of Milan
| 4 years |
| Donatella Cungi | F | 63 |
University of Milan
| 3 years |
| Jean Pierre Seveke | M | 62 |
University of Milan
| 4 years |
| Dario Moresco | M | 61 |
University of Milan
| 3 years |
| Roberto Lancellotti | M | 59 |
University of Milan
| 4 years |
| Egidio Cozzi | M | 57 |
University of Milan
| 4 years |
| Matteo Bonelli | M | 55 |
University of Milan
| 3 years |
| Maria Grazia Filippini | F | 59 |
University of Milan
| 4 years |
| Alberto Ferdinando Toffoletto | M | 63 |
University of Milan
| 3 years |
| Danilo Penati | M | 60 |
University of Milan
| 4 years |
| Marco Claudio Grillo | M | 55 |
University of Milan
| 4 years |
| Luigi Francesco Gozzini | M | 57 |
University of Milan
| 4 years |
| Andrea Zaglio | M | 57 |
University of Milan
| 1 years |
| Paola Casali | F | 56 |
University of Milan
| 3 years |
| Michael Bergamini | M | - | 5 years | |
| Staffan Strömberg | M | 57 | 4 years | |
| Bengt Ingemar Samuelsson | M | 90 | 15 years | |
| Francesca Rasetti | M | 58 |
University of Milan
| 4 years |
| Alberta Figari | F | 60 |
University of Milan
| 3 years |
| Eric Castaldi | M | 59 | 16 years | |
| Pascal Pfister | M | 66 | 5 years | |
| Sergio Tamborini | M | 65 |
University of Milan
| 4 years |
| Paolo Melloni | M | 63 |
University of Milan
| 2 years |
| Giacomo Foglia | M | 61 |
University of Milan
| 4 years |
| Andreas Segerros | M | 63 | 2 years | |
| Alvise Sagramoso | M | 68 |
University of Milan
| 4 years |
| Carlo Pavesi | M | 60 |
University of Milan
| 3 years |
| Andrea Costa | M | 64 |
University of Milan
| 4 years |
| Andrea Rabusin | M | - |
University of Milan
| 4 years |
| Alessandra della Porta | F | 60 |
University of Milan
| 3 years |
| Carola Rita della Porta | F | 59 |
University of Milan
| 4 years |
| Giorgio Mosconi | M | 63 |
University of Milan
| 3 years |
| Elizabeth Marie Robinson | M | - | - | |
| Vicente J. Anido | M | 71 | 1 years | |
| Frank Baldino | M | 71 | 9 years | |
| Luca Alippi | M | 61 |
University of Milan
| 4 years |
| Damian Marron | M | 62 | 6 years | |
| Andrea Gambirasio | M | 56 |
University of Milan
| 4 years |
| Jacques Djian | M | - | - | |
| Jean-Luc Bélingard | M | 74 | 9 years | |
| Valerio Verderio | M | - |
University of Milan
| 4 years |
| Barbara Masella | F | 59 |
University of Milan
| 4 years |
| Mario Notari | M | 59 |
University of Milan
| 3 years |
| Luca Minoli | M | 63 |
University of Milan
| 3 years |
| Anna Chiara Svelto | F | 55 |
University of Milan
| 3 years |
| Paolo Lecchi | M | - |
University of Milan
| 3 years |
| Alessandro Malacart | M | 63 |
University of Milan
| 5 years |
| Nicla Picchi | F | 63 |
University of Milan
| 3 years |
| Roberto Mazzei | M | 62 |
University of Milan
| 18 years |
| Gian Paolo Rizzardi | M | - |
University of Milan
| 3 years |
| Kenneth Coleman | M | 75 |
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | - |
| Alessandro de Carli | M | - |
University of Milan
| 4 years |
| Giorgio Luca Bruno | M | 64 |
University of Milan
| 4 years |
| Filippo Gazzola | M | 60 |
University of Milan
| 3 years |
| Nicolò Romani | M | 57 |
University of Milan
| 4 years |
| Sandro Ferrari | M | - |
University of Milan
| 4 years |
| Claudio Tatozzi | M | 55 |
University of Milan
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Italy | 68 | 68.00% |
| France | 29 | 29.00% |
| United States | 5 | 5.00% |
| Israel | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michele Garufi
- Personal Network
